Practicalities in running early-phase trials using the time-to-event continual reassessment method (TiTE-CRM) for interventions with long toxicity periods using two radiotherapy oncology trials as examples

Ítems similars

• Practicalities in running early-phase trials using the time-to-event continual reassessment method (TiTE-CRM) for interventions with long toxicity periods using two radiotherapy oncology trials as examples
  per: Erik van Werkhoven, et al.
  Publicat: (2020-06-01)
• Minimum effective dose of a multicomponent behaviour change intervention to increase the physical activity of individuals on primary statin therapy: an adaptive study using the time-to-event continual reassessment method (TiTE-CRM)
  per: Karina W Davidson, et al.
  Publicat: (2025-08-01)
• Challenges in implementing model-based phase I designs in a grant-funded clinical trials unit
  per: Eleni Frangou, et al.
  Publicat: (2017-12-01)
• Challenges in implementing model-based phase I designs in a grant-funded clinical trials unit
  per: Frangou, Eleni, et al.
  Publicat: (2017)
• Phase I study of continuous MKC-1 in patients with advanced or metastatic solid malignancies using the modified Time-to-Event Continual Reassessment Method (TITE-CRM) dose escalation design
  per: Tevaarwerk, Amye, et al.
  Publicat: (2011)